Kaposi's sarcoma: A result of the interplay among inflammatory cytokines, angiogenic factors and viral agents

Cytokine and Growth Factor Reviews

Volumn 9, Issue 1, 1998, Pages 63-83

  Ensoli, Barbara ^a   Stürzl, Michael ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

AIDS; Angiogenic factors; Bcl 2; CD8 T cells; Circulating spindle cell progenitors; Human herpesvirus 8; Inflammatory cytokines; IV 1 Tat; Kaposi's sarcoma; Monocytes macrophages

Indexed keywords

ANGIOGENIC FACTOR; CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANGIOGENESIS; ANIMAL; CYTOKINE RELEASE; DISEASE ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; IMMUNOLOGY; IMMUNOSTIMULATION; INFLAMMATION; KAPOSI SARCOMA; MALIGNANT TRANSFORMATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALIA; HERPESVIRIDAE; HERPESVIRUS 8; HUMAN HERPESVIRUS 8;

EID: 0345367426     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(97)00037-3     Document Type: Article

References (215)

1. Friedman-Kien AE. Disseminated Kaposi's sarcoma syndrome in young homosexual men. J Am Acad Dermatol 1981, 5, 468-471.
2. Haverkos HW, Drotman DP. Prevalence of Kaposi's sarcoma among patients with AIDS. New Engl J Med 1985, 312, 1518.
3. Safai B, Johnson KG, Myskowski PL, et al. The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Int Med 1985, 103, 744-750.
4. Slavin G, Cameron HM, Singh H. Kaposi's sarcoma in mainland Tanzania: a report of 117 cases. Brit J Cancer 1969, 23, 349-357.
5. Taylor JF, Smith PG, Bull D, Pike MC. Kaposi's sarcoma in Uganda: geographic and ethnic distribution. Brit J Cancer 1972, 6, 483-497.
6. Geddes M, Franceschi M, Balzi D, Arniani S, Gafà L, Zanetti R. Birthplace and classic Kaposi's sarcoma in Italy. J Natl Cancer Inst 1995, 87, 1015-1017.
7. Franceschi S, Geddes M. Epidemiology of classic Kaposi's sarcoma, with special reference to Mediterranean population. Tumori 1995, 81, 308-314.
8. Penn I. Kaposi's sarcoma in organ transplant recipients: report of 20 cases. Transplantation 1979, 27, 8-11.
9. Trattner A, Hodak E, David M, Sandbank M. The appearance of Kaposi's sarcoma during corticosteroid therapy. Cancer 1993, 72, 1779-1783.
10. Brooks JJ. Kaposi's sarcoma: a reversible hyperplasia. Lancet 1986, 2, 1309-1311.
11. Levy JA, Ziegler JL. Acquired immunodeficiency syndrome is an opportunistic infection and Kaposi's sarcoma results from secondary immune stimulation. Lancet 1983, 2, 78-81.
12. Real F, Krown SE. Spontaneous regression of Kaposi's sarcoma in patients with AIDS. N Engl J Med 1985, 313, 1659.
13. Ensoli B, Salahuddin SZ, Gallo RC. AIDS-associated Kaposi's sarcoma: A molecular model for its pathogenesis. Cancer Cells 1989, 1, 93-96.
14. Ensoli B, Barillari G, Gallo RC. Pathogenesis of AIDS-related Kaposi's sarcoma. Hematol Oncol Clin North Am 1991, 5, 281-295.
15. Ensoli B, Gallo RC. Growth factors in AIDS-associated Kaposi's sarcoma: cytokines and HIV-I Tat protein. In DeVita V Jr, Hellman S, Rosenberg SA, eds. AIDS Updates. Philadelphia, J.B. Lippincott Co., 1994, 7, 1-12.
16. Roth WK, Brandstetter H, Stürzl M. Cellular and molecular features of HIV-associated Kaposi's sarcoma. AIDS 1992, 6, 895-913.
17. Ruszczak Z, Mayer-Da Silva A, Orfanos CE. Angioproliferative changes in clinically noninvolved, perilesional skin in AIDS-associated Kaposi's sarcoma. Dermatologica, 1987, 175, 270-279.
18. Ruszczak Z, Mayer-Da Silva A, Orfanos CE. Kaposi's sarcoma in AIDS. Am J Dermatopath 1987, 9, 388-398.
19. McNutt NS, Fletcher V, Conant MA. Early lesions of Kaposi's sarcoma in homosexual men. An ultrastructural comparison with other vascular proliferations in skin. Am J Pathol 1983, 111, 62-77.
20. Dorfman RF, Path FRC. The histogenesis of Kaposi's sarcoma. Lymphology 1984, 17, 76-77.
21. Ensoli B, Gallo RC. AIDS-associated Kaposi's sarcoma: A new perspective of its pathogenesis and treatment. Proc Assoc Am Physicians 1995, 107, 8-18.
22. Stürzl M, Brandstetter H, Roth WK. Kaposi's sarcoma: a review of gene expression and ultrastructure of KS spindle cells in vivo. AIDS Res Hum Retrov 1992, 8, 1753-1763.
23. + T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with HIV-1 Tat protein: an immune response to HHV-8 infection. Blood 1998, 91, 956-967.
24. MacPhail LA, Dekker NP, Regezi JA. Macrophages and vascular adhesion molecules in oral Kaposi's sarcoma. J Cutaneous Pathol 1996, 23, 464-472.
25. Regezi SA, MacPhail LA, Daniels TE, De Souza YG, Greenspan JS, Greenspan D. Human immunodeficiency virus-associated oral Kaposi's sarcoma: a heterogeneous cell population dominated by spindle-shaped endothelial cells. Am J Pathol 1993, 43, 240-249.
26. Nickoloff BJ, Griffiths CEM. Factor XIIIa-expressing dermal dendrocytes in AIDS-associated cutaneous Kaposi's sarcomas. Science 1989, 243, 1736-1737.
27. Uccini S, Ruco LP, Monardo F, et al. Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells. J Pathol 1994, 173, 23-31.
28. Uccini S, Sirianni MC, Vincenzi L, et al. Kaposi's sarcoma (KS) cells express the macrophage associated antigen mannose receptor and develop in peripheral blood cultures of KS patients. Am J Pathol 1997, 150, 929-938.
29. Tabata M, Langford A, Becker J, Reichart PA. Distribution of immunocompetent cells in oral Kaposi's sarcoma (AIDS). Oral Oncol 1993, 29B, 209-213.
30. Sirianni MC, Vincenzi L, Fiorelli V, et al. γ-interferon production in peripheral blood mononuclear cells (PBMC) and tumour infiltrating lymphocytes from Kaposi's sarcoma patients: correlation with the presence of human herpesvirus-8 in PBMC and lesional macrophages. Blood 1998, 91, 968-976.
31. Nadji M, Morales AR, Zigler-Weissman J, Pehneys NS. Kaposi's sarcoma: immunohistologic evidence for an endothelial origin. Arch Pathol Lab Med 1981, 105, 274-275.
32. Little D, Said W, Siegel RJ, Fealy M, Fishbein MC. Endothelial cell markers in vascular neoplasms: an immunohistochemical study comparing factor VHIII-related antigen, blood group specific antigens, 6-keto-PGF1α, and Ulex Europaeus 1 lectin. J Pathol 1986, 149, 89-95.
33. Kraffert C, Planus L, Penneys NS. Kaposi's sarcoma: further immunohistologic evidence of a vascular endothelial origin. Arch Dermatol 1991, 127, 1734-1735.
34. Gendelman R, Fiorelli V, Kao V, Gallo RC, Ensoli B. Spindle cells from both AIDS-associated and classical Kaposi's sarcoma (KS) lesions are of endothelial cell origin and present an activated phenotype. AIDS Res Hum Retrov 1994, 10, S101.
35. Kaaya EE, Parravicini C, Ordonez C, et al. Heterogeneity of spindle cells in Kaposi's sarcoma: comparison of cells in lesions and culture. J Acq Immun Def Synd Hum Retrov 1995, 10, 295-305.
36. Fiorelli V, Markham P, Gendelman R, Ensoli B. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J Clin Invest 1995, 95, 1723-1734.
37. Yang J, Xu Y, Zhu C, Hagan MK, Lawley T, Hoffermann MK. Regulation of adhesion molecular expression in Kaposi's sarcoma cells. J Immunol 1994, 152, 361-373.
38. Huang YQ, Friedman-Kien AE, Li JJ, Nickoloff BJ. Cultured Kaposi's sarcoma cell lines express factor XIIIa, CD14, and VCAM-1, but not factor VIII or ELAM-1. Arch of Dermatol 1993, 129, 1291-1296.
39. Corbeil J, Evans LA, Vasak E, Cooper DA, Penny R. Culture and properties of cells derived from Kaposi sarcoma. J Immunol 1991, 146, 2972-2976.
40. Zhang YM, Bachmann S, Hemmer C, et al. Vascular origin of Kaposi's sarcoma: expression of leucocyte endothelial adhesion molecule-1, thrombomodulin, and tissue factor. Am J Pathol 1994, 144, 51-59.
41. Pammer J, Plettenberg A, Weninger W, et al. CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma. Am J Pathol 1996, 148, 1387-1396.
42. + T cells. Science 1988, 242, 427-430.
43. Barillari G, Buonaguro L, Fiorelli V, et al. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression: Implications for AIDS-Kaposi's sarcoma pathogenesis. J Immunol 1992, 149, 3727-3734.
44. Barillari G, Gendelman R, Gallo RC, Ensoli B. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc Natl Acad Sci USA 1993, 90, 7941-7945.
45. Albini A, Barillari G, Benelli R, Gallo RC, Ensoli B. Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci USA 1995, 92, 4838-4842.
46. Samaniego F, Markham P, Gallo RC, Ensoli B. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice. J Immunol 1995, 154, 3582-3592.
47. Samaniego F, Markham PD, Gendelman R, Gallo RC, Ensoli B. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice. J Immunol 1997, 158, 1887-1894.
48. Salahuddin SZ, Nakamura S, Biberfeld P, et al. Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science 1988, 242, 430-433.
49. Ensoli B, Nakamura S, Salahuddin SZ, et al. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 1989, 243, 223-226.
50. Ensoli B, Gendelman R, Markham P, et al. Synergy between basic fibroblast growth factor and human immunodeficiency virus type 1 Tat protein in induction of Kaposi's sarcoma. Nature 1994, 371, 674-680.
51. Ensoli B, Markham P, Kao V, et al. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis and lesion formation in nude mice by antisense oligonucleotides targeting basic fibroblast growth factor: a novel strategy for the therapy of KS. J Clin Invest 1994, 94, 1736-1746.
52. Lunardi-Iskandar Y, Gill P, Lam V, et al. A neoplastic cell line (KS Y-1) from Kaposi's sarcoma (KS): evidence that late stage KS can be a true malignancy. J Natl Cancer Inst 1995, 87, 974-981.
53. Herndier BG, Werner A, Arnstein P, et al. Characterization of a human Kaposi's sarcoma cell line that induces angiogenic tumors in animals. AIDS 1994, 8, 575-581.
54. Rabkin CS, Janz S, Lash A, et al. Monoclonal origin of multicentric Kaposi's sarcoma lesions. New Engl J Med 1997, 336, 988-993.
55. Gill P, Tsai Y, Rao AP, Jones P. Clonality in Kaposi's sarcoma. New Engl J Med 1997, 337, 570-571.
56. + patients. Nature Med 1995, 1, 65-68.
57. Maurice PD, Smith NP, Pinching AJ. Kaposi's sarcoma with benign course in a homosexual. Lancet 1982, 1, 571.
58. + cells in HIV-1-infected and high risk individuals. Clin Immunol Immunop 1994, 73, 252-260.
59. Ballard HS. Disseminated Kaposi's sarcoma without lymphocyte abnormalities. Arch Intern Med 1985, 145, 547.
60. DePaoli P, Caffau C, D'Andrea M, Tavio M, Tirelli U, Santini G. Serum levels of intercellular adhesion molecule 1 in patients with HIV-1 related Kaposi's sarcoma. J Acq Immun Def Synd 1994, 7, 695-699
61. Jaffe HW, Choi K, Thomas PA, et al. National case-control study of Kaposi's sarcoma and Pneumocyctis carinii pneumonia in homosexual men: part 1, epidemiological results. Ann Intern Med 1983, 99, 145-151.
62. Fan J, Bass HZ, Fahev JL. Elevated IFNγ and decreased IL-2 gene expression are associated with HIV-1 infection. J Immunol 1993, 151, 5031-5040.
63. Hober D, Haque A, Wattre P, Beucaire G, Mouton Y, Capron A. Production of tumor necrosis factor γ (TNFα) and interleukin 1 (IL-1) in patients with AIDS. Enhanced level of TNFα is related to higher cytotoxic activity. Clin Exp Immunol 1989, 78, 329-333.
64. Honda M, Kitamura K, Mizutani Y, et al. Quantitative analysis of serum IL-6. and its correlation with increased levels of serum IL2R in HIV-1-induced disease. J Immunol 1990, 145, 4059-4064.
65. Lahdevirta J, Maury CPJ, Teppo AM, Repo H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am J Med 1988, 85, 289-291.
66. Lepe-Zanuga JL, Mansell TWA, Hersh EM. Idiopathic production of Interleukin-1 in acquired immunodeficiency syndrome. J Clin Microbiol 1987, 5, 1695-1700.
67. Vyakarnam A, Matear P, Meager A, et al. Alterated production of tumor necrosis factors α and β and interferon γ by HIV-1 infected individuals. Clin Exp Immunol 1991, 84, 109-115.
68. Caruso A, Gonzales R, Stellini R, Scalzini A, Peroni L, Turano A. Interferon-γ marks activated T lymphocytes in AIDS patients. AIDS Res Hum Retrov 1990, 6, 899-940.
69. Hahn T, Schattner A, Handzel ZT, Levin S, Bentwich Z. Possible role of natural cytotoxic activity in the pathogenesis of AIDS. Clin Immunol Immunopathol 1989, 50, 53-61.
70. + lymphocytes. Clin Exp Immunol 1993, 93, 350-355.
71. Master SP, Taylor JF, Kyalwazi SK, Ziegler JL. Immunologic studies in Kaposi's sarcoma in Uganda. Brit Med J 1970, 1, 600-602.
72. Kestens L, Melbye M, Biggar RJ, et al. Endemic African Kaposi's sarcoma is not associated with immunodeficiency. Int J Canc 1985, 36, 49-54.
73. Rizzardini G, Piconi S, Ruzzante S, et al. Immunological activation markers in the serum of African and European HIV-seropositive and seronegative individuals. AIDS 1996, 10, 1535-1542.
74. Fagiolo U, Cossarizza A, Scala E, et al. Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol 1993, 23, 2375-2378.
75. Levin MJ, Murray M, Rotbart HA, Zerbe GO, White CJ, Hayward AR. Immune response of elderly individual to live attenuated varicella vaccine. J Infect Dis 1992, 166, 253-259.
76. Beckstead JH. Oral presentation of Kaposi's sarcoma in a patient without severe immunodeficiency. Arch Pathol Lab Med 1992, 116, 543-545.
77. Aboulafia D, Miles SA, Saks SR, Mitsuyasu RT. Intravenous recombinant tumor necrosis factor in the treatment of AIDS-related Kaposi's sarcoma. J Acq Immun Def Synd 1989, 2, 54-58.
78. Albrecht H, Stellbrink H-J, Gross G, Berg B, Helmchen U, Mensing H. Treatment of atypical leishmaniasis with interferon γ resulting in progression of Kaposi's sarcoma in an AIDS patient. Clin Invest 1994, 72, 1041-1047.
79. Krigel RL, Odajnyk CM, Laubenstein LJ, et al. Therapeutic trial of interferon γ in patients with epidemic Kaposi's sarcoma. J Biol Response Mod 1985, 4, 358-364.
80. Krigel RL, Padavic-Shaller KA, Rudolph AR, Poiesz BJ, Comis RL. Exacerbation of epidemic Kaposi's sarcoma with a combination of interleukin-2 and γ interferon: results of a phase 2 study. J Biol Response Mod 1989, 8, 359-365.
81. Mitsuyasu RT. Clinical aspects of AIDS-related Kaposi's sarcoma. In Abeloff MD, Klastersky J, eds. Current Opinion in Oncology, Baltimore, Current Science, 1993, 5, 835-844.
82. Cotran RS, Pober JS. Endothelial activation: its role in inflammatory and immune reaction. In Simionescu N, Simionescu M, eds. Endothelial Cell Biology. New York, Plenum Publishing, 1988, 335-347.
83. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Phys Rev 1990, 70, 427-451.
84. Tannenbaum SH, Gralnick HR. γ-interferon modulates von Willenbrand factor release by cultured human endothelial cells. Blood 1990, 75, 2177-2184.
85. Zietz C, Hotz B, Stürzl M, Rauch E, Penning R, Löhrs U. Aortic endothelium in HIV-1 infection: chronic injury, activation and increased leukocyte adherence. Am J Pathol 1996, 149, 1887-1898.
86. Browning PJ, Sechler JMG, Kaplan M, et al. Identification and culture of Kaposi's sarcoma-like spindle cells from the peripheral blood of HIV-1-infected individuals and normal controls. Blood 1994, 84, 2711-2720.
87. Sirianni MC, Uccini S, Angeloni A, Faggioni A, Cottoni F, Ensoli B. Circulating spindle cells: correlation with human herpesvirus-8 (HHV-8) infection and Kaposi's sarcoma. Lancet 1997, 349, 225.
88. Colombini S, Monini P, Stürzl H, et al. The inflammatory cytokines increased in Kaposi's sarcoma reactivate human herpesvirus-8 infection in B cells and monocytes and promote the development of latently infected spindle cells. Submitted.
89. Lampugnani MG, Resnati M, Raitieri M, et al. A novel endothelial-specific membrane protein is a marker of cell-cell contacts. J Cell Biol 1992, 118, 1511-1522.
90. Miles SA, Rezai AR, Salazar-Gonzalez JF, et al. AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc Natl Acad Sci USA 1990, 87, 4068-4072.
91. Oxholm A, Oxholm P, Permin H, Bendtzen K. Epidermal tumour necrosis factor (α) and interleukin 6-like activities in AIDS-related Kaposi's sarcoma. Acta Pathol Mic Sc 1989, 97, 533-538.
92. Stürzl M, Brandstetter H, Zietz C, et al. Identification of interleukin-1 and platelet-derived growth factor-β as major mitogens for the spindle cells of Kaposi's sarcoma: a combined in vitro and in vivo analysis. Oncogene 1995, 10, 2007-2016.
93. Yang J, Hagan M, Offerman MK. Induction of IL-6 gene expression in Kaposi's sarcoma cells. J Immunol 1994, 152, 943-955.
94. Ensoli B, Barillari G, Gallo RC. Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma. Immunol Rev 1992, 66, 147-155.
95. Faris M, Ensoli B, Kokot N, Nel AE. Inflammatory cytokines induce the expression of bFGF isoforms required for growth of Kaposi's sarcoma and endothelial cells through the activation of AP-1 response elements of the bFGF promoter. AIDS in press.
96. Nair BC, DeVico AL, Nakamura S, et al. Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science 1992, 255, 1430-1432.
97. Miles SA, Martinez-Maza O, Rezai A, et al. Oncostatin M as a potent mitogen for AIDS-KS-derived cells. Science 1992, 255, 1432-1434.
98. Cai J, Gill PS, Masood P, et al. Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma. Am J Pathol 1994, 145, 74-79.
99. Faris M, Ensoli B, Stahl N, et al. Differential activation of the ERK, Jun Kinase and Janus Kinase-Stat pathways by oncostatin M and basic fibroblast growth factor in AIDS-derived Kaposi's sarcoma cells. AIDS 1996, 10, 369-378.
100. Wijelath Es, Carisen B, Cole T, Chen J, Kotharl S, Hammond WP. Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology. J Cell Sci 1997, 100, 871-879.
101. Takashima S, Klagsbrun M. Inhibition of endothelial cell growth by macrophage-like U-937 cell derived oncostatin M, leukemia inhibitory factor, and transforming growth factor β1. J Biol Chem 1996, 271, 24901-24906.
102. Barillari G, Gendelman R, Fiorelli V, et al. HIV-1 Tat protein promotes angiogenesis triggered with inflammatory cytokines by retrieving heparin-bound basic fibroblast growth factor and by engaging the αvβ3 integrin. Submitted.
103. Montesano R, Orci L, Vassalli P. Human endothelial cell cultures: phenotypic modulation by leukocyte interleukins. J Cell Physiol 1985, 122, 424-434.
104. Liu YJ, Mason DY, Johnson GD, et al. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol 1991, 21, 1905-1910.
105. Bohan-Morris C, Gendelman R, Marrogi AJ, et al. Immunohistochemical detection of bcl-2. in AIDS-associated and classical Kaposi's sarcoma. Am J Pathol 1996, 148, 1055-1063.
106. Felipe Samaniego, Phillip D. Markham, Rita Gendelman, et al. Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Are Expressed in Kaposi's Sarcoma and Synergize to induce Angiogenesis, Vascular Permeability and KS Lesion Development: Induction by Inflammatory Cytokines. Am. J. Pathol. (in press).
107. Weindel K, Marmé D, Weich HA. AIDS associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor. Biochem Bioph Res Co 1992, 183, 1167-1174.
108. Cornali E, Zietz C, Benelli R, et al. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am J Pathol 1996, 149, 1851-1869.
109. Chang H-K, Gallo RC, Ensoli B. Regulation of cellular gene expression and function by the human immunodeficiency virus type 1 Tat protein. J Biomed Sci 1995, 2, 189-202.
110. Xerri L, Hausson J, Planche J, et al. Fibroblast growth factor gene expression in AIDS - Kaposi's sarcoma detected by in situ hybridization. Am J Pathol 1991, 138, 9-15.
111. Masood R, Cai J, Zheng T, Smith DL, Naidu Y, Gill PS. Vascular endothelial growth factor/vascular permeability factor is an autocrine growth for AIDS - Kaposi's sarcoma. Proc Natl Acad Sci USA 1997, 94, 979-984.
112. Brown LF, Tognazzi, K, Dvorak HF, Harrist TJ. Strong expression of kinase insert domain-containing receptor, a vascular permeability factor/vascular endothelial growth factor receptor in AIDS-associated Kaposi's sarcoma and cutaneous angiosarcoma. Am J Pathol 1996, 148, 1065-1074.
113. Rosen EM, Goldberg ID. Scatter factor and angiogenesis. Adv Cancer Res 1995, 67, 257-279.
114. Naidu YM, Rosen EM, Zitnick R, et al. Role of scatter factor in the pathogenesis of AIDS-related Kaposi's sarcoma. Proc Natl Acad Sci USA 1994, 91, 5281-5285.
115. Maier JA, Mariotti M, Albini A, et al. Over-expression of hepatocyte growth factor in human Kaposi's sarcoma. Int J Cancer 1996, 65, 168-172.
116. Roth WK, Werner S, Schirren CG, Hofschneider PH. Depletion of PDGF from serum inhibits growth of AIDS-related and sporadic Kaposi's sarcoma cells in culture. Oncogene 1989, 4, 483-487.
117. Werner S, Hofschneider PH, Heldin CH, Ostman A, Roth WK. Cultured Kaposi's sarcoma-derived cells express functional PDGF-A type and B-type receptors. Exp Cell Res 1990, 187, 98-103.
118. Stürzl M, Roth WK, Brockmeyer NH, Zietz C, Speiser B, Hofschneider PH. Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi's sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance. Proc Natl Acad Sci USA 1992, 89, 7046-7050.
119. Brown DM, Hong SP, Farell CL, Pierce GF, Khouri RK. Platelet-derived growth factor BB induces functional vascular anastomoses in vivo. Proc Natl Acad Sci USA 1995, 92, 5920-5924.
120. Mantovani A, Bussolino F, Introna M. Cytokine regulation of endothelial cell function: from molecular level to the bedside. Immunol Today 1997, 18, 231-240.
121. Murakami-Mori K, Taga T, Kishimoto T, Nakamura S. AIDS-associated Kaposi's sarcoma (KS) cell express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6. receptor. J Clin Invest 1995, 96, 1319-1327.
122. Murakami-Mori K, Taga T, Kishimoto T, Nakamura S. The soluble form of IL-6 receptor (sIL-6R α) is a potent growth factor for AIDS-associated Kaposi's sarcoma (KS) cells; the soluble form of gp130. is antagonistic for sIL-6R α-induced AIDS-KS cell growth. International Immunol 1996, 8, 595-602.
123. Sciacca FL, Stürzl M, Bussolino F, et al. Expression of adhesion molecules, platelet-activating factor, and chemokines by Kaposi's sarcoma cells. J Immunol 1994, 153, 4816-4825.
124. Stürzl M, Cornali E, Gahlemann C, et al. Expression of growth factors, cytokines, and chemokines in Kaposi's sarcoma in HIV and cytokines. M. Guneounou, eds. Les Editions INSERM, 1997, 349-357.
125. Bussolino F, Wang JM, De Filippi P. Granulocyte and granulocyte-macrophages colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 1989, 337, 471-473.
126. Clark SC, Kamen R. The human hematopoietic colony stimulating factors. Science 1987, 236, 1229-1236.
127. Werner PH, Hofschneider PH, Stürzl M, Dick I, Roth WK. Cytochemical and molecular properties of simian virus 40 transformed Kaposi's sarcoma-derived cells: evidence for the secretion of a member of the fibroblast growth factor family. J Cell Physiol 1989, 141, 490-502.
128. Li JJ, Huang YQ, Moscatelli D, Nicolaides A, Zhang WC, Friedman-Kien AE. Expression of fibroblast growth factors and their receptors in acquired immunodeficiency syndrome-associated Kaposi's sarcoma tissue and derived cells. Cancer 1993, 72, 2253-2259.
129. Roth WK, Werner S, Hofschneider PH. Autocrine and paracrine growth stimulation of Kaposi's sarcoma derived cell cultures. VI International Conference on AIDS. San Francisco, 1990, Abstract ThA321.
130. Bussolino F, Arese M, Montrucchio G, et al. Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis. J Clin Invest 1995, 96, 940-952.
131. Werner S, Viehweger P, Hofschneider PH, Roth WK. Low mitogenic response to EGF and TGF-α: A characteristics feature of cultured Kaposi's sarcoma derived cells. Oncogene 1991, 6, 59-64.
132. Roth WK. TGF-β and FGF-like growth factors involved in the pathogenesis of AIDS-associated Kaposi's sarcoma. Res Virol 1993, 144, 105-109.
133. Williams AO, Ward JM, LI JF, Jackson MA, Flanders KC. Immunohistochemical localization of transforming growth factor-β 1 in Kaposi's sarcoma. Hum Pathol 1995, 26, 469-473.
134. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266, 1865-1869.
135. Ambroziak JA, Blackbourn DJ, Herndier BG, et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients. Science 1995, 268, 582-583.
136. Boshoff C, Acholz T, Kennedy MM, et al. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nature Med 1995, 1, 1274-1278.
137. Schalling M, Ekman M, Kaaya EE, Linde A, Biberfeld P. A role for a new herpesvirus (KSHV) in different forms of Kaposi's sarcoma. Nature Med 1995, 1, 707-708.
138. Huang YQ, Li JJ, Kaplan MH, et al. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 1995, 345, 759-762.
139. Buonaguro FM, Tornesello ML, Beth-Giraldo E, et al. Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int J Cancer 1996, 65, 25-28.
140. Albini A, Aluigi MG, Benelli R, et al. Oncogenesis in HIV-infection: KSHV and Kaposi's sarcoma. Int J Oncol 1996, 9, 5-8.
141. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995, 86, 1276-1280.
142. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995, 332, 1186-1191.
143. Dupin N, Gorin I, Deleuze J, Agut H, Huraux J-M, Escande J-P. Herpes-like DNA sequences, AIDS-related tumors, and Castleman's disease. N Engl J Med 1995, 333, 799.
144. Otsuki T, Kumar S, Ensoli B, et al. Detection of HHV-8/KSHV DNA sequences in AIDS-associated extranodal lymphoid malignancies. Leukemia 1996, 10, 1358-1362.
145. Rettig MB, Ma HJ, Vascio RA, et al. Kaposi's sarcoma-associated herpesvirus infection of bone marrow dendritic cells from multiple myeloma patients. Science 1997, 276, 1851-1854.
146. Kedes DH, Operskalski E, Busch M, Kohn R, Fllod J, Ganem D. The seroepidemiology of human herpesvirus-8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nature Med 1996, 2, 918-924.
147. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type-8 in the general population and in Kaposi's sarcoma patients. Lancet 1996, 348, 858-861.
148. Rezza G, Lennette ET, Giuliani M, et al. Prevalence and determinants of anti-lytic and anti-latent antibodies to HHV-8 among Italian individuals at risk of sexually and parenterally transmitted infections. Submitted.
149. Monini P, De Lellis L, Fabris M, Rigolin F, Cassai E. Kaposi's sarcoma herpesvirus (KSHV) is a ubiquitous virus frequently present in prostate tissue and human sperm. N Engl J Med 1996, 334, 1168-1172.
150. Blackbourn DJ, Ambroziak J, Lennette E, Adams M, Ramachandran B, Levy JA. Infectious human herpesvirus 8 in a healthy North American blood donor. Lancet 1997, 349, 609-611.
151. De Lellis L, Fabris M, Cassai E, et al. Herpesvirus-like DNA sequences in non-AIDS Kaposi's sarcoma. J Infect Dis 1995, 172, 1605-1607.
152. Bigoni B, Dolcetti R, De Lellis L, et al. Human Herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS. J Infec Dis 1996, 173, 542-549.
153. Viviano E, Vitale F, Ajello F, et al. Human herpesvirus type 8 DNA sequences in biological samples of HIV-positive and negative individuals in Sicily. AIDS 1997, 11, 607-612.
154. Corbellino M, Poirel L, Bestetti G, et al. Restricted tissue distribution of extralesional Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS patients with Kaposi's sarcoma. AIDS Res Human Retrov 1996, 12, 651-657.
155. Decker LL, Shankar P, Khan G, et al. The Kaposi's sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J Exp Med 1996, 184, 283-288.
156. Huang J-O, Feiner D, Zhang WG, Cockerell CJ, Demopoulos RD, Friedman-Kien AE. Detection of HHV-8 in tissues of various organs from AIDS-KS patients. Abstract Book of the XI Int. Conference on AIDS. Vancouver 1996, 2, 8.
157. Gao S, Kingsley L, Hoover DR, et al. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 1996, 335, 233-241.
158. Simpson GR, Schulz TF, Whitby D, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996, 349, 1133-1138.
159. Rizzieri DA, Liu J, Miralles D, Traweek ST. Kaposi's sarcoma-associated herpesvirus is detected in peripheral blood mononuclear cells of HIV-infected homosexuals more often than in heterosexuals. Cancer J Sci Am 1997, 3, 153-156.
160. Purvis SF, Katongole-Mbidde E, Johnson JL, et al. High incidence of Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus in tumor lesions and peripheral blood mononuclear cells from patients with Kaposi's sarcoma in Uganda. J Infect Dis 1997, 175, 947-950.
161. Kasolo FC, Mpabalwani E, Gompels UA. Infection with AIDS-related herpesviruses in human immunodeficiency virus-negative infants and endemic childhood Kaposi's sarcoma in Africa. J Gen Virol 1997, 78, 847-855.
162. Moore PS, Kingsley L, Holmberg SD, et al. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS 1996, 10, 175-180.
163. Whitby D, Howard MR, Tenant-Flowers M, et al. Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet, 1995, 346, 799-803.
164. Mesri EA, Cesarman E, Arvanitakis L, et al. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J Exp Med 1995, 183, 2385-2390.
165. Harrington MJ, Bagasra O, Sosa CE, et al. Human herpesvirus type 8 DNA sequences in cell-free plasma and mononuclear cells of Kaposi's sarcoma patients. J Infect Dis 1996, 174, 1101-1105.
166. Blasig C, Zietz C, Haar B, et al. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus-8. J Virol 1997, 10, 7963-7968.
167. Stürzl M, Blasig C, Schreier A, et al. Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma (KS). Int J Cancer 1997, 72, 68-71.
168. Boshoff C, Whitby D, Hatzioannou T, et al. Kaposi's sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995, 345, 1043-1044.
169. Li JJ, Huang YQ, Cockerell CJ, Friedman-Kien AE. Localization of human herpes-like virus type 8 in vascular endothelial cells and perivascular spindle-shaped cells of Kaposi's sarcoma lesions by in situ hybridization. Am J Pathol 1996, 148, 1741-1748.
170. Staskus KA, Zhong W, Gebhard K, et al. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 1997, 71, 715-719.
171. Rainbow L, Platt GM, Simpson GR, et al. The 222- to 23-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf 73 and is a component of the latency-associated nuclear antigen. J Virol 1997, 71, 5915-5921.
172. Orenstein JM, Alkan S, Blauvelt A, et al. Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy. AIDS 1997, 11, 35-45.
173. Dictor M, Rambech E, Way D, Witte M, Bendsoe N. Human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients. Am J Pathol 1996, 148, 2009-2016.
174. Lebbé C, de Crémoux P, Rybojad M, et al. Kaposi's sarcoma and new herpesvirus. Lancet 1995, 345, 1180.
175. Maiorana A, Luppi M, Barozzi P, Collina G, Fano RA, Torelli G. Detection of human herpes virus type 8 DNA sequences as a valuable aid in the differential diagnosis of Kaposi's sarcoma. Modern Pathol 1997, 10, 182-187.
176. Noel JC. Kaposi's sarcoma and KSHV. Lancet 1995, 346, 1359.
177. Neipel F, Albrecht JC, Ensser A, et al. Human herpesvirus 8 encodes a homolog of interleukin-6. J Virol 1997, 71, 839-842.
178. Neipel F, Albrecht J-C, Fleckenstein B. Cell-homologs genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8; determinants of its pathogenicity. J Virol 1997, 71, 4187-4192.
179. Russo JJ, Bohenzky RA, Chien MC, et al. Nucleotide sequence of the Kaposi's sarcoma-associated herpesvirus (HHV-8). Proc Natl Acad Sci USA 1996, 93, 14862-14867.
180. Sarid R, Sato T, Bohenzky RA, Russo JJ, Chang Y. Kaposi's sarcoma-associated herpesvirus encodes a functional bcl-2 homologue. Nature Med 1997, 3, 293-298.
181. Nicholas J, Cameron KR, Honess RH. Herpesvirus saimiri encodes homologues of G protein-coupled receptors and cyclins. Nature 1992, 355, 362-365.
182. Cesarman E, Nador RG, Bai F, et al. Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol 1996, 70, 8218- 8223.
183. Chang Y, Moore PS, Talbot SJ, et al. Cyclin encoded by KS herpesvirus. Nature 1996, 382, 410.
184. Moore PS, Boshoff C, Weiss RA, Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 1996, 274, 1739-1744.
185. Stürzl M, Ascherl G, Blasig C, Opalenik SR, Ensoli B, Browning PJ. Expression of the human herpesvirus 8 (HHV-8) encoded MIP-I gene (v-MIP-I) in Kaposi's sarcoma (KS) lesions. AIDS (in press).
186. Davis MA, Stürzl M, Blasig C, et al. Latent expression of human herpesvirus 8-encoded cyclin gene in Kaposi's sarcoma. J Natl Cancer I 1997, 189, 1868-1874.
187. Boshoff C, Talbot S, Whitby D, Reeves J, Weiss RA. AIDS associated tumors and HHV8. J Acqu Immun Def Synd Hum Retrov 1997, 14, S9.
188. + T cells in acute infectious mononucleosis. Nature Med 1996, 2, 906-911.
189. Arya SK, Guo C, Josephs SF, Wong-Staal F. Transactivator gene of human T-lymphotropic virus type III (HTLV-III). Science 1985, 229, 69-73.
190. Ensoli B, Buonaguro L, Barillari G, et al. Release, uptake, and effects of extracellular HIV-1 Tat protein on cell growth and viral transactivation. J Virol 1993, 67, 277-287.
191. Ensoli B, Barillari G, Salahuddin SZ, Gallo RC, Wong-Staal F. The Tat protein of HIV-1 ]stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 1990, 345, 84-86.
192. Chang HC, Samaniego F, Nair BC, Buonaguro L, Ensoli B. HIV-1. Tat protein exits from cells via leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS 1997, 11, 1421-1431.
193. Vogel J, Hinrichs SH, Reynolds RK, Luciw PA, Jay G. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 1988, 335, 601-661.
194. Corallini A, Altavilla G, Pozzi L, et al. Systemic expression of HIV-1 tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes. Cancer Res 1993, 53, 5569-5575.
195. Strömblad S, Cheresh DA. Cell adhesion and angiogenesis. Cell Biol 1996, 6, 462-468.
196. Barillari G, Fiorelli V, Gendelman R, et al. HIV-1 Tat protein enhances angiogenesis and Kaposi's sarcoma (KS) development triggered by inflammatory cytokines (IC) or bFGF by engaging the αvβ3 integrin. J Acq Immun Def Synd Hum Retrov 1997, 14, A33.
197. Albini A, Fontanini G, Masiello L, et al. Angiogenic potential in vivo by Kaposi'sarcoma cell-free supernatants and HIV-1 Tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2. AIDS 1994, 8, 1237-1244.
198. Lafrenie RM, Wahl LM, Epstein JS, Hewlett IK, Yamada KM, Dhawan S. HIV-1 Tat protein promotes chemataxis and invasive behavior by monocytes. J Immunol 1996, 157, 974-977.
199. Albini A, Soldi R, Giunciuglio D, et al. The angiogenesis induced by HIV-1 Tat protein is mediated by the FIk/1/KDR receptor on vascular endothelial cells. Nature Med 1996, 2, 1371-1375.
200. Buonaguro L, Buonaguro FM, Giraldo G, Ensoli B. The human immunodeficiency virus type 1 Tat protein transactivates tumor necrosis factor β gene expression through a TAR-like structure. J Virol 1994, 68, 2677-2682.
201. Scala G, Ruocco MR, Ambrosino C, et al. The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 Tat protein. J Exp Med 1994, 179, 961-971.
202. Zauli G, Davis BR, Re MC, Visani G, Furlini G, La Placa M. Tat protein stimulates production of transforming growth factor-β 1 by marrow macrophages: a potential mechanism for human immunodeficiency virus-1-induced hematopoietic suppression. Blood 1992, 80, 3036-3043.
203. Hofman FM, Wright AD, Dohadwala MM, Wong-Staal F, Walker SM. Exogenous Tat protein activates human endothelial cells. Blood 1993, 82, 2774-2780.
204. Domingo Kelly G, Ensoli B, Gunthel CJ, Offermann MK. Induction of inflammatory response genes by purified Tat in Kaposi's sarcoma cells. Submitted.
205. Harrington W, Sieczkowski L, Sosa C, et al. Activation of HHV-8 by HIV-1 Tat. Lancet 1997, 349, 774.
206. Zauli G, Gibellini D, Caputo A, et al. The human immunodeficiency virus type 1 Tat protein upregulates bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells. Blood 1995, 86, 3823-3834.
207. Westendorp MO, Frank R, Ochsenbauer C, et al. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 1995, 275, 497-500.
208. Montmayeur F, Krajewski S, Bejui-Thivolet F, et al. In vivo patterns of apoptosis-regulating protein expression in Kaposi's sarcoma. Appl Immunohistohemistry 1997, 5, 104-110.
209. Saville MW, Lietzau J, Pluda JM, et al. Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. Lancet 1995, 346, 26-28.
210. Haldar S, Jena N, Croce CM. Inactivation of bcl-2. by phosphorylation. Proc Natl Acad Sci USA 1995, 92, 4507-4511.
211. Spandidos DA, Kaloterakis A, Yiagnisis M, Varatsos A, Field JK. Ras, c-myc and c-erbB-2 oncoprotein expression in non-AIDS mediterrranean Kaposi's sarcoma. Anticoncer Res 1990, 10, 1619-1626.
212. Huang YQ, Li JJ, Moscatelli D, et al. Expresion of the int-2 oncogene in Kaposi's sarcoma lesions. J Clin Invest 1993, 91, 1191-1197.
213. Scincariello F, Dolan MJ, Nedelcu I, Tyring SK, Hillard JK. Occurrence of human papillomavirus and p53 gene mutations in Kaposi's sarcoma. J Virol 1994, 203, 153-157.
214. Bergman R, Ramon M, Kilim S, Lichtig C, Friedman-Birnbaum R. An immunohistochemical study of p53 protein expression in classical Kaposi's sarcoma. Am J Dermatol 1996, 18, 367-370.
215. Köster R, Blatt LM, Streubert M, et al. Consensus-interferon and platelet-derived growth factor adversely regulate proliferation and migration of Kaposi's sarcoma cells by control of c-myc expression. Am J Pathol 1996, 149, 1871-1885.